Cite
HARVARD Citation
Reale, A. et al. (2021). TOP2A expression predicts responsiveness to carfilzomib in myeloma and informs novel combinatorial strategies for enhanced proteasome inhibitor cell killing. Leukemia & lymphoma. 62 (2), pp. 337-347. [Online].